1021704

Eli Lilly & Company — FEI 1819470

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 28, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Indianapolis, IN (United States)

Additional Details

Sponsor, Contract Research Organization